Very limited options
Safe and effective treatment for both intestinal inflammation and extra-intestinal manifestations remains elusive.
Ailm Biologics
The elusive pro-resolution treatment for complex inflammatory diseases
We resolve complex inflammatory disease comprehensively — restoring homeostasis rather than managing symptoms.
We resolve. Comprehensively.
Ailm Biologics is revolutionizing the treatment of complex inflammatory diseases. You can either focus on management of the symptoms or resolve the disease. We resolve.
The challenge
The problem
Patients with lifelong, debilitating diseases affecting multiple organs and daily function deserve better options.
Limited efficacy
High rates of non-responders and refractory patients leave many without adequate care.
Fragmented care
IBD and extra-intestinal manifestations often require separate, incompatible treatments.
Unsafe solutions
Current therapies frequently involve chronic immunosuppression with significant long-term risk.
Our solution
Fixing complex inflammatory disease at its roots
Our initial target is IBD with HLA B27-associated spondyloarthropathies.
We are developing a plasmid-based therapy restoring immune homeostasis across gut and systemic inflammation — a first-in-class approach designed to resolve, not manage, chronic complex inflammation.
View pipelineNon-immunosuppressive
Restores comprehensive homeostasis by a roots-up approach, not by suppressing immunity.
Multi-pathway impact
Targets microbiome, gut barrier, and immune regulation simultaneously.
Differentiated mechanism
ABX-90i is designed to shift biology from disease back to homeostasis.
Partner with us
Advancing pro-resolution therapy for complex inflammatory disease
We welcome inquiries from potential partners, investors, and collaborators aligned with our mission to resolve — not manage — chronic inflammation.